NCT04151849View on ClinicalTrials.gov

Effects of Diabetes Medications on Adrenal Function and Intestinal Microbiota

CompletedOBSERVATIONAL
Enrollment

23

Participants

Timeline

Start Date

November 7, 2019

Primary Completion Date

January 23, 2023

Study Completion Date

January 23, 2023

Conditions
Type 2 Diabetes
Interventions
DRUG

GLP-1 receptor agonist

Treatment with GLP-1 agonist for up to 1 year.

DRUG

SGLT2 inhibitor

Treatment with SGLT2 inhibitor for up to 1 year

Trial Locations (1)

Unknown

Tartu University Hospital, Tartu

All Listed Sponsors
lead

University of Tartu

OTHER

NCT04151849 - Effects of Diabetes Medications on Adrenal Function and Intestinal Microbiota | Biotech Hunter | Biotech Hunter